NIGP 26936: Diagnostic Agents

NIGP 26936 Diagnostic Agents, an Item code, encompasses the procurement of medical diagnostic products and laboratory reagents by state and local public bodies, including naloxone, drug deactivation systems, immunoassay kits, antibodies, genomics reagents, hematology products, and related clinical diagnostics supplies. State and local issuing bodies under this code include county health departments, university health science centers, and community health organizations that acquire these materials through competitive sealed bidding and RFPs to support emergency response programs, clinical laboratory operations, and biotech research initiatives. Vendors typically supply products on a recurring or routine basis through e-procurement portals and punchout catalogs, with quarterly or ongoing deliveries to health facilities and research centers. Contracts generally carry initial terms of one to two years with renewal options and require vendors to meet insurance, E-Verify, and compliance documentation standards.

Recent opportunities show activity in Florida and Texas. Seminole County, Florida released IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its community health building and a response deadline of July 26, 2023. The University of Texas Health Science Center at San Antonio issued RFP 745-26-P19 in May 2026 for a comprehensive biotech research and clinical diagnostics catalog including antibodies, chromatography systems, flow cytometry instruments, genomics reagents, and immunoassay kits, with proposals due June 4, 2026; the prior contract year reflected approximately 8,768 line items ordered, and UTHSA requires HUB subcontracting plans and TX-RAMP Level II certification from proposers.